Sponsor pipeline

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics clinical trial pipeline

Get alerts when Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-13 NCT07872033 Aleniglipron Hepatic Impairment Study Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
1
Phase 2
1
Phase 3
2

Disease areas by active trials

Obesity (3) · Diabetes (2) · Type 2 Diabetes (2)

Get alerts when Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free